Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy.
暂无分享,去创建一个
L. Tavazzi | E. Arbustini | A. Gavazzi | B. Dal Bello | A. Pilotto | J. Narula | M. Grasso | M. Diegoli | M. Viganó | P. Morbini | B. D. Bello | F. Magani | M. Grasso | N. Banchieri | M. Vigano' | Filippo Magani
[1] R. Heilig,et al. An informative polymorphism detectable by polymerase chain reaction at the 3′ end of the dystrophin gene , 1990, Human Genetics.
[2] L. Tavazzi,et al. Heart failure-related myopathy. Clinical and pathophysiological insights. , 1999, European heart journal.
[3] M. Martone,et al. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.
[4] G. Comi,et al. Coexistence of mitochondrial DNA and β myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure , 1998, Heart.
[5] E. Arbustini,et al. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. , 1998, The American journal of pathology.
[6] F. Muntoni,et al. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. , 1998, American journal of human genetics.
[7] A. Nakamura,et al. Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy. , 1998, Human molecular genetics.
[8] E. Arbustini,et al. Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. , 1998, Journal of the American College of Cardiology.
[9] P. Jongen,et al. The heart in limb girdle muscular dystrophy , 1998, Heart.
[10] E. Arbustini,et al. Recent Advances in Etiopathogenesis of Dilated Cardiomyopathy: Which Relevance for the Clinical Cardiologist? , 1998 .
[11] K. Campbell,et al. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy. , 1997, Journal of molecular and cellular cardiology.
[12] L. Mestroni,et al. Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy , 1997, Heart.
[13] E. Arbustini,et al. Enteroviral RNA and virus-like particles in the skeletal muscle of patients with idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.
[14] Jason T. Su,et al. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. , 1997, Circulation.
[15] E. Arbustini,et al. Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up. , 1997, Giornale italiano di cardiologia.
[16] G. Danieli,et al. Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. , 1996, Circulation.
[17] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[18] L. Mestroni,et al. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. , 1996, Human molecular genetics.
[19] E. Arbustini,et al. Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. , 1995, American heart journal.
[20] W. Fogel,et al. X‐Linked Dilated Cardiomyopathy , 1995 .
[21] W. Fogel,et al. X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene. , 1995, Annals of the New York Academy of Sciences.
[22] L. Politano,et al. Mutation of dystrophin gene and cardiomyopathy , 1994, Neuromuscular Disorders.
[23] E. Arbustini,et al. Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy , 1994, Neuromuscular Disorders.
[24] E. Hoffman,et al. Restoration of half the normal dystrophin sequence in a double-deletion Duchenne muscular dystrophy family. , 1994, American journal of medical genetics.
[25] F. Muntoni,et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. , 1993, The New England journal of medicine.
[26] J. Towbin,et al. X‐Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy (Dystrophin) Gene at the Xp21 Locus , 1993, Circulation.
[27] C. Doriguzzi,et al. Dilating cardiomyopathy as the expression of Xp21 Becker type muscular dystrophy , 1992, Journal of the Neurological Sciences.
[28] E. Arbustini,et al. H and L ferritins in myocardium in iron overload. , 1991, The American journal of cardiology.
[29] R. Gibbs,et al. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. , 1991, American journal of human genetics.
[30] R. Heilig,et al. Nonradioactive assay for new microsatellite polymorphisms at the 5' end of the dystrophin gene, and estimation of intragenic recombination. , 1991, American journal of human genetics.
[31] Nobelstiftelsen,et al. Etiology of Human Disease at the DNA Level , 1991 .
[32] L. Kunkel,et al. Rapid detection of CA polymorphisms in cloned DNA: application to the 5' region of the dystrophin gene. , 1991, American journal of human genetics.
[33] R A Gibbs,et al. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. , 1988, Nucleic acids research.
[34] J. Towbin,et al. X-linked dilated cardiomyopathy. , 1987, The New England journal of medicine.
[35] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[36] B. Mokri,et al. Duchenne dystrophy , 1975, Neurology.